Tower Research Capital LLC (Trc) Medicinova Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Medicinova Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,352 shares of MNOV stock, worth $5,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,352
Previous 2,321
44.42%
Holding current value
$5,229
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding MNOV
# of Institutions
29Shares Held
5.13MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.73 Million0.54% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$972,3990.0% of portfolio
-
Geode Capital Management, LLC Boston, MA515KShares$803,2650.0% of portfolio
-
Citigroup Inc502KShares$783,0520.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $76.5M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...